Reliance Life Sciences Launches U.S.Clinical Research Subsidiary
Mumbai, India-based Reliance Life Sciences has opened a U.S. subsidiary of its four-year old contract research organization (CRO) Reliance Clinical Research Services (RCRS). The U.S. unit will be based in Newtown, Pa., and will offer clinical research and molecular diagnostic services to sponsors.
Changing Regulatory and Economic Standards Boost Evidence Market
Bethesda, Md.-based United BioSource Corporation (UBC), global investment management firm Goldman Sachs and former high ranking federal regulators discussed evidence or post-approval outcomes research and its impact on clinical trials and future medical treatments at a a recent summit in New York. The event was called: “The New Evidence Landscape: The Impact of Changing Regulatory and Economic Standards on Clinical Innovation and Product Commercialization.”
Other Breaking News...
PharmaNet reports first quarter revenue increase...
